PTK7 and ovarian carcinoma: The measured KDAPP of 10–44 nM matches the affinity previously reported for the same chOI-1 antibody in an ovarian cancer model, showing that chOI-1 retains comparable PTK7 binding across both ovarian and bladder cancer cells (Lindland et al. 2025).